The role of endothelial cells and their progenitors in intimal hyperplasia

Intimal hyperplasia leading to restenosis is the major process that limits the success of cardiovascular intervention. The emergence of vascular progenitor cells and, in particular, endothelial progenitor cells has led to great interest in their potential therapeutic value in preventing intimal hyperplasia. We review the mechanism of intimal hyperplasia and highlight the important attenuating role played by a functional endothelium. The role of endothelial progenitor cells in maintaining endothelial function is reviewed and we describe how reduced progenitor cell number and function and reduced endothelial function lead to an increased risk of intimal hyperplasia. We review other potential sources of endothelial cells, including monocytes, mesenchymal stem cells and tissue resident stem cells. Endothelial progenitor cells have been used in clinical trials to reduce the risk of restenosis with varied success. Progenitor cells have huge therapeutic potential to prevent intimal hyperplasia but a more detailed understanding of vascular progenitor cell biology is necessary before further clinical trials are commenced.

[1]  G. Schuler,et al.  Effects of Exercise and Ischemia on Mobilization and Functional Activation of Blood-Derived Progenitor Cells in Patients With Ischemic Syndromes: Results of 3 Randomized Studies , 2005, Circulation.

[2]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[3]  F. C. Lucibello,et al.  Endothelial-like cells derived from human CD14 positive monocytes. , 2000, Differentiation; research in biological diversity.

[4]  J. J. Griffin,et al.  Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial , 2000, The Lancet.

[5]  R R Markwald,et al.  Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.

[6]  T. Akasaka,et al.  The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. , 2006, Internal medicine.

[7]  Endothelial progenitor cell mobilization after percutaneous coronary intervention. , 2006 .

[8]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[9]  M. Pesce,et al.  SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. , 2004, Blood.

[10]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[11]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[12]  M. Endres,et al.  Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. , 2003, Circulation.

[13]  R. Mango,et al.  The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. , 2010, International journal of cardiology.

[14]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[15]  R. Cummings,et al.  Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[16]  A. Hingorani,et al.  Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. , 2000, Journal of vascular surgery.

[17]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[19]  M. Kelm,et al.  Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.

[20]  T. Finkel,et al.  Endothelial progenitor cells. , 2005, Annual review of medicine.

[21]  J. C. Geer,et al.  Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery. , 1983, Archives of pathology & laboratory medicine.

[22]  M. Goodell,et al.  Hematopoietic potential of stem cells isolated from murine skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Isner,et al.  Histopathology of in-stent restenosis in patients with peripheral artery disease. , 1997, Circulation.

[24]  S. Dimmeler,et al.  Endothelial progenitor cells functional characterization. , 2004, Trends in cardiovascular medicine.

[25]  R. Cummings,et al.  Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[26]  F. Welt,et al.  Inflammation and Restenosis in the Stent Era , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Number and Adhesive Properties of Circulating Endothelial Progenitor Cells in Patients With In-Stent Restenosis , 2003 .

[28]  G. Montalescot,et al.  Drug eluting stents: an updated meta-analysis of randomised controlled trials , 2005, Heart.

[29]  Mingyao Liu,et al.  Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium , 2004, Regulatory Peptides.

[30]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T Stijnen,et al.  Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. , 2001, Radiology.

[32]  M. Yoder,et al.  Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.

[33]  H. Drexler,et al.  Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.

[34]  Qingbo Xu,et al.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. , 2004, The Journal of clinical investigation.

[35]  Stefanie Dimmeler,et al.  Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells , 2003, Circulation.

[36]  ToyoakiMurohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001 .

[37]  A. Clowes,et al.  Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.

[38]  P. Serruys,et al.  Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[39]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[40]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[41]  JinHur,et al.  Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation , 2003 .

[42]  StefanieDimmeler,et al.  Aging and Disease as Modifiers of Efficacy of Cell Therapy , 2008 .

[43]  Qingbo Xu,et al.  Endothelial progenitor cells are mobilized after cardiac surgery. , 2007, The Annals of thoracic surgery.

[44]  F. Welt,et al.  Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted , 2002, Circulation research.

[45]  Qingbo Xu,et al.  Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells , 2003 .

[46]  Smith Sh,et al.  Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery. , 1983 .

[47]  J. Huard,et al.  Muscle-Derived Stem Cells , 2004, Gene therapy.

[48]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[49]  L. Williams,et al.  Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Chi‐Hang Lee,et al.  Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. , 2008, American heart journal.

[51]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[52]  S M Schwartz,et al.  Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.

[53]  N. Wright,et al.  Circulating mesenchymal stem cells. , 2004, The international journal of biochemistry & cell biology.

[54]  P. Serruys,et al.  Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[55]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[56]  Xing-xiang Wang,et al.  Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. , 2004, Clinical science.

[57]  Peter Carmeliet,et al.  VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  J. Badimón,et al.  CCR2 Deficiency Decreases Intimal Hyperplasia After Arterial Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[59]  H. Miller,et al.  Comparative analysis of methods for assessment of circulating endothelial progenitor cells. , 2006, Tissue engineering.

[60]  K. Burnand,et al.  Recurrent carotid stenosis after carotid endarterectomy , 1997, The British journal of surgery.

[61]  H. Kubo,et al.  Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. , 2004, Biochemical and biophysical research communications.

[62]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[63]  Seil Oh,et al.  Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation , 2003, Circulation.

[64]  ToyoakiMurohara,et al.  Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004 .

[65]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[66]  J. Corson,et al.  Relationship between vasa vasorum and blood flow to vein bypass endothelial morphology. , 1985, Archives of surgery.

[67]  Robert J Anderson,et al.  Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. , 2004, Journal of the American College of Cardiology.

[68]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[69]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[70]  J. Isner,et al.  Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. , 1995, Circulation.

[71]  P. Armstrong,et al.  Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. , 1994, Circulation research.

[72]  A. Zernecke,et al.  SDF-1&agr;/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells , 2005, Circulation research.

[73]  H. Daida,et al.  Isolation of Bone Marrow Stromal Cell–Derived Smooth Muscle Cells by a Human SM22&agr; Promoter: In Vitro Differentiation of Putative Smooth Muscle Progenitor Cells of Bone Marrow , 2003, Circulation.

[74]  U. Laufs,et al.  Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury , 2003, Circulation research.

[75]  T. Suda,et al.  Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. , 2002, Blood.

[76]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[77]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[78]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[79]  Takamitsu Nakamura,et al.  Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. , 2005, Journal of the American College of Cardiology.

[80]  T. Katagiri,et al.  Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[81]  M. Lever,et al.  Changes in vein interstitium following distension for aortocoronary bypass. , 1989, The Journal of cardiovascular surgery.

[82]  柏倉 祐司.  Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22α promoter : In vitro differentiation of putative smooth muscle progenitor cells of bone marrow , 2004 .

[83]  AndreaMezzetti,et al.  Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty , 2001 .

[84]  N. Caplice,et al.  Smooth Muscle Progenitor Cells in Human Blood , 2002, Circulation.

[85]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[86]  V. Pasceri,et al.  Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation , 2005, Circulation.

[87]  Qingbo Xu,et al.  Circulating Progenitor Cells Regenerate Endothelium of Vein Graft Atherosclerosis, Which Is Diminished in ApoE-Deficient Mice , 2003, Circulation research.

[88]  J. Gimble,et al.  Surface protein characterization of human adipose tissue‐derived stromal cells , 2001, Journal of cellular physiology.

[89]  A. Clowes,et al.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. , 1990, The American journal of pathology.

[90]  M. Klomp,et al.  Design and rationale of the TRI-stent adjudication study (TRIAS) program. , 2009, American heart journal.

[91]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[92]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[93]  M. Fishbein,et al.  A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. , 1991, Journal of the American College of Cardiology.

[94]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.

[95]  H. Matsubara,et al.  Granulocyte Colony-Stimulating Factor–Mobilized Circulating c-Kit+/Flk-1+ Progenitor Cells Regenerate Endothelium and Inhibit Neointimal Hyperplasia After Vascular Injury , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[96]  D. Simon,et al.  Molecular Basis of Restenosis and Drug-Eluting Stents , 2005, Circulation.

[97]  D. Strunk,et al.  Blood Monocytes Mimic Endothelial Progenitor Cells , 2006, Stem cells.

[98]  F. Timmermans,et al.  Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.

[99]  S. Rafii,et al.  Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 , 2001, Annals of the New York Academy of Sciences.

[100]  R. Palmer,et al.  Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[101]  M. Makuuchi,et al.  Circulating smooth muscle progenitor cells contribute to atherosclerosis , 2001, Nature Medicine.

[102]  KohOno,et al.  Anti–Monocyte Chemoattractant Protein-1/Monocyte Chemotactic and Activating Factor Antibody Inhibits Neointimal Hyperplasia in Injured Rat Carotid Arteries , 1999 .

[103]  J. Hartikainen,et al.  Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.

[104]  M. Gnecchi,et al.  Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries , 2004, Circulation.

[105]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[106]  Y. Yoon,et al.  Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis , 2004, Circulation.

[107]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[108]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[109]  R. Busse,et al.  Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. , 1999, Diabetes.

[110]  E L Ritman,et al.  Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. , 1998, Journal of the American College of Cardiology.

[111]  G. Patti,et al.  Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody‐coated stent: A prospective single‐center registry in high‐risk patients , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[112]  J. Hartikainen,et al.  Intravascular Adenovirus-Mediated VEGF-C Gene Transfer Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta , 2000, Circulation.

[113]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[114]  N. Olson,et al.  Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. , 1992, The Journal of clinical investigation.

[115]  R. Virmani,et al.  Extracellular Matrix Changes in Stented Human Coronary Arteries , 2004, Circulation.

[116]  D. Gospodarowicz,et al.  Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.

[117]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[118]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[119]  H. Matsubara,et al.  Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells , 2003, Circulation research.

[120]  J. Falkenburg,et al.  Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2002, Experimental hematology.

[121]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[122]  A. Riecker,et al.  Systematic Review of Early Recurrent Stenosis After Carotid Angioplasty and Stenting , 2005, Stroke.

[123]  A. Luttun,et al.  Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[124]  J. Mills,et al.  The histologic characteristics of primary and restenotic carotid plaque. , 1998, The Journal of surgical research.

[125]  Yao‐Hua Song,et al.  Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. , 2007, European heart journal.

[126]  A. Ma,et al.  Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. , 2006, International journal of cardiology.

[127]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[128]  M. Endres,et al.  Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[129]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[130]  H. Ohgushi,et al.  Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. , 2004, American journal of physiology. Heart and circulatory physiology.

[131]  B. Hibbert,et al.  c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. , 2004, American journal of physiology. Heart and circulatory physiology.

[132]  W. Hozack,et al.  A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone , 2003, Molecular biotechnology.

[133]  J Kievit,et al.  Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. , 1998, Stroke.

[134]  G. Lawrie,et al.  Spasm of saphenous veins used as conduits for aortocoronary bypass grafting , 1988 .

[135]  P. Serruys,et al.  Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. , 2005, Journal of the American College of Cardiology.

[136]  QingboXu,et al.  Both Donor and Recipient Origins of Smooth Muscle Cells in Vein Graft Atherosclerotic Lesions , 2002 .

[137]  S. Ishiwata,et al.  Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. , 1997, American heart journal.

[138]  S. Verma,et al.  Endothelial function testing as a biomarker of vascular disease. , 2003, Circulation.

[139]  A. Mangi,et al.  Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells , 2004, Circulation.

[140]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[141]  David J Cohen,et al.  Are drug-eluting stents cost-effective? It depends on whom you ask. , 2006, Circulation.